Carolyn R. Bertozzi

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when ELI LILLY & Co publishes a filing, an earnings call transcript or a press release.

Get LLY alerts

About Carolyn R. Bertozzi

Carolyn R. Bertozzi is recorded as Board Member at ELI LILLY & Co (LLY) since December 8, 2025. ELI LILLY & Co reported in an 8-K filed November 21, 2025 that Carolyn R. Bertozzi was appointed new member of the Board, effective December 8, 2025. ELI LILLY & Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at ELI LILLY & Co includes Juan Luciano (CEO), David Ricks (Chairman and Board Member), Kimberly Johnson (COO) and 5 others.

“On November 18, 2025, the Board of Directors (the “Board”) of Eli Lilly and Company (the “Company”) elected Carolyn R. Bertozzi, Ph.D as a new member of the Board, effective December 8, 2025.”

ELI LILLY & Co Form 8-K, filed November 21, 2025 · Read the filing

Affiliation history

ELI LILLY & Co (LLY)
Board Member

SEC 8-K

Current
2025-12-08–present
ELI LILLY & Co (LLY)
Board Member

SEC 8-K

2025-12-08–2021-08-23

Company network

ELI LILLY & Co

LLY

Current role

Drug Manufacturers - General · Healthcare

Board Member

2025-12-08–present

Leadership on record at ELI LILLY & Co

Juan Luciano CEO
David Ricks Chairman, Board Member
Kimberly Johnson COO
Anat Hakim General Counsel
Carolyn Bertozzi Board Member
Dr. Mary Lynne Hedley Board Member
Jon Moeller Board Member
William Kaelin Board Member

Recent activity

Executive change Appointed: new member of the Board ELI LILLY & Co (LLY)
2025-12-08